Systems | Development | Analytics | API | Testing

Why BI vendors are holding back on innovation

When it comes to automation in the BI industry, I think a lot of vendors are holding back. It’s entirely possible to automate the majority of what data analysts do today, but vendors are reluctant to do this because it would impact data analysts and they’re a big gatekeeper in the buying cycle of analytic software.

Unravel Launches Performance Management and Cloud Migration Assessment Solution for Google Cloud Dataproc

We are very excited to announce that Unravel is now available for Google Cloud Dataproc. If you are already on GCP Dataproc or on a journey to migrate on-premises data workloads to GCP Dataproc then Unravel is now available immediately to accelerate and de-risk your Dataproc migration and ensure performance SLAs and cost targets are achieved.

"Being in the Zone" with Augmented Intelligence

According to positive psychologist Mihály Csíkszentmihályi, what I described with this skiing experience is known as flow state, defined as an “optimal state of consciousness where we feel our best and perform our best.” Csíkszentmihályi, who popularized the term in his 1990 book, notes the mental state of flow involves “Being completely involved in an activity for its own sake. The ego falls away. Time flies.

Innovation in the BI industry is dead

Innovation in the BI industry died about 30 years ago. Sure the colors and format may be different but what’s delivered to business users is exactly the same and that's a real problem. I think this is because the industry spends more time thinking about how to make a data analyst’s life easier rather than helping business users get the most value from their data.

Accelerating Innovation in Precision Medicine by Leveraging Cloud and AI/ML

At Hitachi Vantara, our mission is to help customers extract all the value of their data through our DataOps methodology, which helps them achieve tangible outcomes that positively drive business and society forward. One field where we’re making advances – which also strikes a personal chord with me, given my background as a biomedical engineer – is in the field of cardiovascular medicine. Specifically, I’m referring to our work with the American Heart Association (AHA).